1016 related articles for article (PubMed ID: 16839274)
21. RNA interference targeting survivin exerts antitumoral effects in vitro and in established glioma xenografts in vivo.
Hendruschk S; Wiedemuth R; Aigner A; Töpfer K; Cartellieri M; Martin D; Kirsch M; Ikonomidou C; Schackert G; Temme A
Neuro Oncol; 2011 Oct; 13(10):1074-89. PubMed ID: 21788344
[TBL] [Abstract][Full Text] [Related]
22. Delivery systems for the direct application of siRNAs to induce RNA interference (RNAi) in vivo.
Aigner A
J Biomed Biotechnol; 2006; 2006(4):71659. PubMed ID: 17057369
[TBL] [Abstract][Full Text] [Related]
23. Systemic delivery of sticky siRNAs targeting the cell cycle for lung tumor metastasis inhibition.
Bonnet ME; Gossart JB; Benoit E; Messmer M; Zounib O; Moreau V; Behr JP; Lenne-Samuel N; Kedinger V; Meulle A; Erbacher P; Bolcato-Bellemin AL
J Control Release; 2013 Sep; 170(2):183-90. PubMed ID: 23727288
[TBL] [Abstract][Full Text] [Related]
24. A mesoporous silica nanoparticle--PEI--fusogenic peptide system for siRNA delivery in cancer therapy.
Li X; Chen Y; Wang M; Ma Y; Xia W; Gu H
Biomaterials; 2013 Jan; 34(4):1391-401. PubMed ID: 23164421
[TBL] [Abstract][Full Text] [Related]
25. Enhanced antitumorigenic effects in glioblastoma on double targeting of pleiotrophin and its receptor ALK.
Grzelinski M; Steinberg F; Martens T; Czubayko F; Lamszus K; Aigner A
Neoplasia; 2009 Feb; 11(2):145-56. PubMed ID: 19177199
[TBL] [Abstract][Full Text] [Related]
26. Sustained delivery of siRNA/PEI complex from in situ forming hydrogels potently inhibits the proliferation of gastric cancer.
Peng H; Yang H; Song L; Zhou Z; Sun J; Du Y; Lu K; Li T; Yin A; Xu J; Wei S
J Exp Clin Cancer Res; 2016 Mar; 35():57. PubMed ID: 27029190
[TBL] [Abstract][Full Text] [Related]
27. Bioreducible polyethylenimine-delivered siRNA targeting human telomerase reverse transcriptase inhibits HepG2 cell growth in vitro and in vivo.
Xia W; Wang P; Lin C; Li Z; Gao X; Wang G; Zhao X
J Control Release; 2012 Feb; 157(3):427-36. PubMed ID: 22036880
[TBL] [Abstract][Full Text] [Related]
28. Induction of in vivo synthetic lethal RNAi responses to treat glioblastoma.
Michiue H; Eguchi A; Scadeng M; Dowdy SF
Cancer Biol Ther; 2009 Dec; 8(23):2306-13. PubMed ID: 19901546
[TBL] [Abstract][Full Text] [Related]
29. An in situ gelling liquid crystalline system based on monoglycerides and polyethylenimine for local delivery of siRNAs.
Borgheti-Cardoso LN; Depieri LV; Kooijmans SA; Diniz H; Calzzani RA; Vicentini FT; van der Meel R; Fantini MC; Iyomasa MM; Schiffelers RM; Bentley MV
Eur J Pharm Sci; 2015 Jul; 74():103-17. PubMed ID: 25917525
[TBL] [Abstract][Full Text] [Related]
30. The effects of transfection reagent polyethyleneimine (PEI) and non-targeting control siRNAs on global gene expression in human aortic smooth muscle cells.
Raof NA; Rajamani D; Chu HC; Gurav A; Johnson JM; LoGerfo FW; Pradhan-Nabzdyk L; Bhasin M
BMC Genomics; 2016 Jan; 17():20. PubMed ID: 26728506
[TBL] [Abstract][Full Text] [Related]
31. [Silence of VEGFR2 expression mediated by PEI/siRNA complexes].
Yang H; Che O; Chen S; Sun L; Ji AM
Yao Xue Xue Bao; 2010 May; 45(5):576-81. PubMed ID: 20931758
[TBL] [Abstract][Full Text] [Related]
32. The suppression of lung tumorigenesis by aerosol-delivered folate-chitosan-graft-polyethylenimine/Akt1 shRNA complexes through the Akt signaling pathway.
Jiang HL; Xu CX; Kim YK; Arote R; Jere D; Lim HT; Cho MH; Cho CS
Biomaterials; 2009 Oct; 30(29):5844-52. PubMed ID: 19640582
[TBL] [Abstract][Full Text] [Related]
33. A plasmid-encoded VEGF siRNA reduces glioblastoma angiogenesis and its combination with interleukin-4 blocks tumor growth in a xenograft mouse model.
Niola F; Evangelisti C; Campagnolo L; Massalini S; Buè MC; Mangiola A; Masotti A; Maira G; Farace MG; Ciafrè SA
Cancer Biol Ther; 2006 Feb; 5(2):174-9. PubMed ID: 16340308
[TBL] [Abstract][Full Text] [Related]
34. Sticky siRNAs targeting survivin and cyclin B1 exert an antitumoral effect on melanoma subcutaneous xenografts and lung metastases.
Kedinger V; Meulle A; Zounib O; Bonnet ME; Gossart JB; Benoit E; Messmer M; Shankaranarayanan P; Behr JP; Erbacher P; Bolcato-Bellemin AL
BMC Cancer; 2013 Jul; 13():338. PubMed ID: 23835136
[TBL] [Abstract][Full Text] [Related]
35. Silica nanoparticles and polyethyleneimine (PEI)-mediated functionalization: a new method of PEI covalent attachment for siRNA delivery applications.
Buchman YK; Lellouche E; Zigdon S; Bechor M; Michaeli S; Lellouche JP
Bioconjug Chem; 2013 Dec; 24(12):2076-87. PubMed ID: 24180511
[TBL] [Abstract][Full Text] [Related]
36. Low-weight polyethylenimine cross-linked 2-hydroxypopyl-β-cyclodextrin and folic acid as an efficient and nontoxic siRNA carrier for gene silencing and tumor inhibition by VEGF siRNA.
Li JM; Wang YY; Zhang W; Su H; Ji LN; Mao ZW
Int J Nanomedicine; 2013; 8():2101-17. PubMed ID: 23766646
[TBL] [Abstract][Full Text] [Related]
37. Pyridylthiourea-grafted polyethylenimine offers an effective assistance to siRNA-mediated gene silencing in vitro and in vivo.
Creusat G; Thomann JS; Maglott A; Pons B; Dontenwill M; Guérin E; Frisch B; Zuber G
J Control Release; 2012 Feb; 157(3):418-26. PubMed ID: 22019558
[TBL] [Abstract][Full Text] [Related]
38. Delivery of siRNA in vitro and in vivo using PEI-capped porous silicon nanoparticles to silence MRP1 and inhibit proliferation in glioblastoma.
Tong WY; Alnakhli M; Bhardwaj R; Apostolou S; Sinha S; Fraser C; Kuchel T; Kuss B; Voelcker NH
J Nanobiotechnology; 2018 Apr; 16(1):38. PubMed ID: 29653579
[TBL] [Abstract][Full Text] [Related]
39. [A pleiotrophin-specific siRNA and its effect on PTEN-/- MEF241 cells].
Hu YC; Liu ML; Li G; Huo YY; Wu DC
Ai Zheng; 2006 Oct; 25(10):1210-5. PubMed ID: 17059762
[TBL] [Abstract][Full Text] [Related]
40. Nonviral in vivo delivery of therapeutic small interfering RNAs.
Aigner A
Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
